Chardan Capital Initiates Coverage on Centessa Pharmaceuticals (NASDAQ:CNTA)
Equities researchers at Chardan Capital assumed coverage on shares of Centessa Pharmaceuticals (NASDAQ:CNTA – Get Free Report) in a note issued to investors on Thursday, Marketbeat reports. The firm set a “buy” rating and a $30.00 price target on the stock. Chardan Capital’s target price would suggest a potential upside of 144.10% from the stock’s […]
Equities researchers at Chardan Capital assumed coverage on shares of Centessa Pharmaceuticals (NASDAQ:CNTA – Get Free Report) in a note issued to investors on Thursday, Marketbeat reports. The firm set a “buy” rating and a $30.00 price target on the stock. Chardan Capital’s target price would suggest a potential upside of 144.10% from the stock’s […]
